| Value | ₹35.00 Cr |
|---|
BSE filing, NSE: NIPPOBATRY. Summary written from the filing by ALFA Finder's alert engine.
Indo National Ltd: key numbers
- Share price
- ₹305.00
- Market cap
- ₹228.8 Cr
- Revenue (annual)
- ₹452.5 Cr
- Net profit (annual)
- ₹-26.34 Cr
- P/E (TTM)
- -9.1×Sector 42.1×
- Promoter holding
- 65.35%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indo National Ltd
All →Indo National Acquisition Worth ₹0.25 Cr
Indo National invested Rs.0.25 Crore in 178 shares of Medcuore Medical Solutions, raising its stake to 63.46%. The acquisition targets growth in air monitoring and purifier business.
- Value
- ₹0.25 Cr
Indo National Other Announcement
Indo National Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory disclosure of shareholding distribution.
Indo National Business Update
Indo-National Ltd approved a Memorandum of Agreement to cease distribution arrangements with Radiohms Agencies, involving a net payment of ₹2.36 Crore for settling inter-se payables.
- Value
- ₹2.36 Cr
Indo National Acquisition Worth ₹3.91 Cr
Indo National Limited has invested ₹3.91 Crore to acquire a further 0.30% stake in Axial Aero Private Limited, bringing its total holding to 7.97%.
- Value
- ₹3.91 Cr
Indo National Acquisition Worth ₹0.5 Cr
Indo National acquired an additional 0.79% stake in Medcuore Medical Solutions for ₹0.50 Crore, taking its total shareholding in the subsidiary to 63.07%.
- Value
- ₹0.50 Cr
- Execution
- Upto FY 2027-28
Indo National Annual General Meeting
Indo National Ltd held its 53rd Annual General Meeting on September 28, 2026. Shareholders transacted ordinary and special business, including dividend declaration and auditor remuneration approval.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr